$ARGX news
The latest ARGX stock news: headlines, filings, AI summaries and sentiment for $ARGX, updated around the clock.
- Ionis Reports Q3 2026 Revenue Growth Driven by DAWNZERA Amid TRYNGOLZA Launch Adjustments
- Pomerantz Law Firm Investigates argenx SE Following Discontinuation of Phase 3 Sjögren's Disease Study
- Iovance Biotherapeutics Reports Q3 2026 Record Revenue Driven by AMTAGVI Growth
- Argenx Projects 2026 Operating Expenses at $4 Billion Amid U.S. Expansion Plans
- Argenx Announces Discontinuation of Late-Stage Trial, Stock Drops
- Two Wall Street Analysts Predict Over 40% Upside for Argenx Shares
- Argenx Reports 18 Consecutive Quarters of Sales Growth and Expanding Profitability
- Argenx Reports Positive Phase 3 Results for Vyvgart Hytrulo in Autoimmune Myositis
- Forte Biosciences Stock Shows Unusual Price Movement Before Argenx Acquisition Announcement
- argenx Acquires Forte Biosciences for $2.2 Billion in Cash
- Forte BioSciences Stock Surges After $2.2 Billion Acquisition Deal with Argenx
- Argenx Acquires Forte Biosciences for $2.2 Billion
- Argenx Agrees to Acquire Forte Biosciences in $2.2 Billion Deal
- Stocks Making Significant Moves Midday: ASML, SK Hynix, SAP, Forte Bio and More
- argenx agrees to acquire Forte Biosciences for $2.2 billion
- argenx Acquires Forte Biosciences for $2.2 Billion to Expand Autoimmune Drug Portfolio
- Premarket Stock Movements: Micron, Forte Biosciences, ExxonMobil, Baker Hughes Among Top Movers
- Argenx Acquires Forte Biosciences for $2.2 Billion to Expand Autoimmune Drug Portfolio
- Forte Biosciences to Be Acquired by argenx for $2.2 Billion
- argenx Acquires Forte Biosciences in $2.2 Billion Cash Deal
- argenx Reports 60% Year-Over-Year Increase in VYVGART Sales
- argenx SE Reports Q2 GAAP EPS of $7.32 and Revenue of $1.52B
- Evercore ISI Raises Price Target for argenx (ARGX)
- Argus Receives Fourth King's Award for Enterprise in International Trade